| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
EstrogenNeuroprotective agentsAndrogens (Pharmacology)Cognitive enhancerObesityEndocrine disruptorRespiratory chainOsteoblastsReceptor (ERR alpha Estrogen receptor related receptor alpha)Matrix metalloproteinaseLymphangioleiomyomatosisMMP2GPR30 GPER1Arthritis (rheumatoid)Systemic lupus erythematosusProgesterone| 1 | 2009 | Neuroprotection by estrogen in the brain: the mitochondrial compartment as presumed therapeutic target. | 
| + | - | nl | J Neurochem 110(1):1-11 (2009) |
| 2 | 2000 | Estrogen as a neuroprotectant in stroke. | 
| + | - | nl | J Cereb Blood Flow Metab 20(4):631-52 (2000) |
| 3 | 2009 | Dose-related neuroprotective versus neurodamaging effects of estrogens in rat cerebral ischemia: a systematic analysis. | 
| + | - | nl | J Cereb Blood Flow Metab 29(8):1359-72 (2009) |
| 4 | 2006 | Estrogens and experimental ischemic stroke: a systematic review. | 
| + | - | nl | J Cereb Blood Flow Metab 26(9):1103-13 (2006) |
| 5 | 2002 | Estrogenic hormone action in the heart: regulatory network and function. | 
| + | - | nl | Cardiovasc Res 53(3):709-19 (2002) |
| 6 | 2004 | Cardiovascular pharmacology of estradiol metabolites. | 
| + | - | nl | J Pharmacol Exp Ther 308(2):403-9 (2004) |
| 7 | 2001 | Estrogenic actions in the brain: estrogen, phytoestrogens, and rapid intracellular signaling mechanisms. | 
| + | - | nl | J Pharmacol Exp Ther 299(2):408-14 (2001) |
| 8 | 2008 | Vascular actions of estrogens: functional implications. | 
| + | - | nl | Pharmacol Rev 60(2):210-41 (2008) |
| 9 | 2001 | Cellular and molecular pharmacology of antiestrogen action and resistance. | 
| + | - | nl | Pharmacol Rev 53(1):25-71 (2001) |
| 10 | 1998 | Basic guide to the mechanisms of antiestrogen action. | 
| + | - | nl | Pharmacol Rev 50(2):151-96 (1998) |
| 11 | 2007 | Sex steroid effects at target tissues: mechanisms of action. | 
| + | - | nl | Adv Physiol Educ 31(1):26-33 (2007) |
| 12 | 2010 | A new approach to understanding the molecular mechanisms through which estrogens affect cognition. | 
| + | - | nl | Biochim Biophys Acta 1800(10):1045-55 (2010) |
| 13 | 2010 | Mitochondrial mechanisms of estrogen neuroprotection. | 
| + | - | nl | Biochim Biophys Acta 1800(10):1113-20 (2010) |
| 14 | 2010 | Diversity of mechanisms involved in aromatase regulation and estrogen action in the brain. | 
| + | - | nl | Biochim Biophys Acta 1800(10):1094-105 (2010) |
| 15 | 2009 | Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors. | 
| + | - | nl | Biochim Biophys Acta 1793(7):1128-43 (2009) |
| 16 | 2009 | Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications. | 
| + | - | nl | Biochim Biophys Acta 1793(10):1540-70 (2009) |
| 17 | 2010 | Estrogen receptors and endothelium. | 
| + | - | nl | Arterioscler Thromb Vasc Biol 30(8):1506-12 (2010) |
| 18 | 2005 | Estrogen receptor-related receptor alpha: a mediator of estrogen response in bone. | 
| + | - | nl | J Clin Endocrinol Metab 90(5):3115-21 (2005) |
| 19 | 2008 | Activation of the estrogen receptor contributes to the progression of pulmonary lymphangioleiomyomatosis via matrix metalloproteinase-induced cell invasiveness. | 
| + | - | nl | J Clin Endocrinol Metab 93(5):1625-33 (2008) |
| 20 | 2010 | Estrogen therapy and cognition: a review of the cholinergic hypothesis. | 
| + | - | nl | Endocr Rev 31(2):224-53 (2010) |
| 21 | 2009 | Mechanisms of estrogen signaling and gene expression via GPR30. | 
| + | - | nl | Mol Cell Endocrinol 308(1-2):32-8 (2009) |
| 22 | 2009 | Membrane-initiated actions of estrogen on the endothelium. | 
| + | - | nl | Mol Cell Endocrinol 308(1-2):3-8 (2009) |
| 23 | 2008 | Estrogen actions on mitochondria--physiological and pathological implications. | 
| + | - | nl | Mol Cell Endocrinol 290(1-2):51-9 (2008) |
| 24 | 2004 | Estrogen metabolites: increasing evidence for their role in rheumatoid arthritis and systemic lupus erythematosus. | 
| + | - | nl | J Rheumatol 31(3):419-21 (2004) |
| 25 | 2008 | Estrogens and progesterone as neuroprotectants: what animal models teach us. | 
| + | - | nl | Front Biosci 13(-):1083-9 (2008) |